Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001610717-23-000278)

Filing Details

Accession Number:: 0001610717-23-000278
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-09-12 17:24:25
Reporting Period:: 2023-09-08

Accepted Time:: 2023-09-12 17:24:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1437402	Ardelyx Inc.	ARDX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1611311	P. David Rosenbaum	C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 100 Fremont CA 94555	Chief Development Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-09-08	2,897	$4.55	367,022	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	114,225	Indirect	By Wife
Common Stock	77,592	Indirect	Family Trust

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.
Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2023.
The shares are directly held by the Reporting Person's wife.
The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.